25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Curexo Inc
Buy, Hold or Sell?

Let's analyze Curexo together

I guess you are interested in Curexo Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Curexo Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Curexo Inc

I send you an email if I find something interesting about Curexo Inc.

1. Quick Overview

1.1. Quick analysis of Curexo (30 sec.)










1.2. What can you expect buying and holding a share of Curexo? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₩2,439.12
Expected worth in 1 year
₩2,446.25
How sure are you?
37.9%

+ What do you gain per year?

Total Gains per Share
₩7.13
Return On Investment
0.1%

For what price can you sell your share?

Current Price per Share
₩7,600.00
Expected price per share
₩5,980 - ₩8,200
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Curexo (5 min.)




Live pricePrice per Share (EOD)
₩7,600.00

2.2. Growth of Curexo (5 min.)




Is Curexo growing?

Current yearPrevious yearGrowGrow %
How rich?$70.1m$62.4m$8m11.4%

How much money is Curexo making?

Current yearPrevious yearGrowGrow %
Making money-$1.7m$358.7k-$2.1m-120.4%
Net Profit Margin-15.3%2.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Curexo (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Curexo?

Welcome investor! Curexo's management wants to use your money to grow the business. In return you get a share of Curexo.

First you should know what it really means to hold a share of Curexo. And how you can make/lose money.

Speculation

The Price per Share of Curexo is ₩7,600. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Curexo.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Curexo, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩2,439.12. Based on the TTM, the Book Value Change Per Share is ₩1.78 per quarter. Based on the YOY, the Book Value Change Per Share is ₩-3.83 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Curexo.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.020.0%-0.040.0%0.010.0%-0.020.0%-0.030.0%
Usd Book Value Change Per Share-0.020.0%0.000.0%0.000.0%0.060.0%0.040.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.020.0%0.000.0%0.000.0%0.060.0%0.040.0%
Usd Price Per Share6.86-10.37-7.57-6.50-5.76-
Price to Earnings Ratio-69.87--34.21-58.37--11.03--9.36-
Price-to-Total Gains Ratio-294.86--6,337.79--9.24--1,335.56--921.54-
Price to Book Ratio4.02-6.03-4.72-5.19-5.42-
Price-to-Total Gains Ratio-294.86--6,337.79--9.24--1,335.56--921.54-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.32
Number of shares187
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.06
Usd Total Gains Per Share0.000.06
Gains per Quarter (187 shares)0.2311.99
Gains per Year (187 shares)0.9347.97
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101-904838
202-809686
303-70144134
404-60192182
505-50240230
606-40288278
707-30336326
807-20384374
908-10432422
100900480470

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%4.08.00.033.3%7.013.00.035.0%7.017.05.024.1%7.017.011.020.0%
Book Value Change Per Share2.02.00.050.0%5.07.00.041.7%9.011.00.045.0%11.018.00.037.9%12.023.00.034.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.029.00.0%0.00.035.00.0%
Total Gains per Share2.02.00.050.0%5.07.00.041.7%9.011.00.045.0%11.018.00.037.9%12.023.00.034.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Curexo Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---33.2371.782-1965%-3.835-88%91.625-136%56.834-158%
Book Value Per Share--2439.1202454.099-1%2241.037+9%1783.682+37%1616.955+51%
Current Ratio--10.70315.413-31%7.401+45%10.7400%7.913+35%
Debt To Asset Ratio--0.0950.074+27%0.135-30%0.138-32%0.186-49%
Debt To Equity Ratio--0.1050.081+30%0.160-35%0.174-40%0.303-65%
Dividend Per Share----0%-0%-0%-0%
Eps---35.065-61.212+75%12.304-385%-35.157+0%-40.938+17%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.828+21%
Market Cap253515480000.000-59%402632902000.000607208859425.000-34%434215124200.000-7%347266720915.000+16%300440390082.323+34%
Net Profit Margin---0.107-0.153+43%0.026-518%-0.123+16%-0.165+55%
Operating Margin----0%-0%-0%-0.2110%
Operating Ratio--1.5161.720-12%1.418+7%1.104+37%1.378+10%
Pb Ratio3.116-29%4.0186.032-33%4.719-15%5.192-23%5.418-26%
Pe Ratio-54.184+22%-69.869-34.208-51%58.371-220%-11.034-84%-9.358-87%
Price Per Share7600.000-29%9800.00014807.500-34%10820.000-9%9286.750+6%8231.725+19%
Price To Free Cash Flow Ratio---64.947-100%102.251-100%27.530-100%18.323-100%
Price To Total Gains Ratio-228.663+22%-294.855-6337.789+2049%-9.244-97%-1335.555+353%-921.539+213%
Quick Ratio---6.571-100%6.601-100%5.642-100%4.126-100%
Return On Assets---0.013-0.023+79%0.005-385%-0.020+53%-0.025+89%
Return On Equity---0.014-0.025+74%0.005-403%-0.022+52%-0.036+149%
Total Gains Per Share---33.2371.782-1965%-3.835-88%91.625-136%56.834-158%
Usd Book Value--70147849.80070467918.2690%62426668.761+12%46325084.248+51%40980851.500+71%
Usd Book Value Change Per Share---0.0230.001-1965%-0.003-88%0.064-136%0.040-158%
Usd Book Value Per Share--1.7071.718-1%1.569+9%1.249+37%1.132+51%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.025-0.043+75%0.009-385%-0.025+0%-0.029+17%
Usd Free Cash Flow----629237.9560%-1579821.2150%-2166607.6610%-2522751.7850%
Usd Market Cap177460836.000-59%281843031.400425046201.598-34%303950586.940-7%243086704.641+16%210308273.058+34%
Usd Price Per Share5.320-29%6.86010.365-34%7.574-9%6.501+6%5.762+19%
Usd Profit---1008465.500-1755894.683+74%358720.917-381%-872239.241-14%-991297.983-2%
Usd Revenue--9459029.30010680894.033-11%12997354.297-27%9763584.625-3%8238529.802+15%
Usd Total Gains Per Share---0.0230.001-1965%-0.003-88%0.064-136%0.040-158%
 EOD+3 -4MRQTTM+12 -15YOY+10 -175Y+17 -1010Y+20 -8

3.3 Fundamental Score

Let's check the fundamental score of Curexo Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-54.184
Price to Book Ratio (EOD)Between0-13.116
Net Profit Margin (MRQ)Greater than0-0.107
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than110.703
Debt to Asset Ratio (MRQ)Less than10.095
Debt to Equity Ratio (MRQ)Less than10.105
Return on Equity (MRQ)Greater than0.15-0.014
Return on Assets (MRQ)Greater than0.05-0.013
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Curexo Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.671
Ma 20Greater thanMa 506,772.500
Ma 50Greater thanMa 1007,063.600
Ma 100Greater thanMa 2008,142.800
OpenGreater thanClose7,550.000
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Curexo Inc

Curexo Inc. engages in the development and sale of medical devices in Korea and internationally. Its products include ROBIN, a robot system that guides needle path induring CT-guided interventional procedure; Baidy, a medical device that assists labor by increasing intrauterine pressure which helps natural childbirth; artificial joint surgical robot; and Gait rehabilitation robot. The company also imports, distributes, and sells food and food additives. Curexo Inc. was founded in 2006 and is headquartered in Seoul, South Korea.

Fundamental data was last updated by Penke on 2024-11-18 17:00:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is overpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Curexo earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Curexo to the Food & Drug Retailing industry mean.
  • A Net Profit Margin of -10.7% means that ₩-0.11 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Curexo Inc:

  • The MRQ is -10.7%. The company is making a huge loss. -2
  • The TTM is -15.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-10.7%TTM-15.3%+4.6%
TTM-15.3%YOY2.6%-17.8%
TTM-15.3%5Y-12.3%-2.9%
5Y-12.3%10Y-16.5%+4.2%
4.3.1.2. Return on Assets

Shows how efficient Curexo is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Curexo to the Food & Drug Retailing industry mean.
  • -1.3% Return on Assets means that Curexo generated ₩-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Curexo Inc:

  • The MRQ is -1.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.3%TTM-2.3%+1.0%
TTM-2.3%YOY0.5%-2.8%
TTM-2.3%5Y-2.0%-0.3%
5Y-2.0%10Y-2.5%+0.5%
4.3.1.3. Return on Equity

Shows how efficient Curexo is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Curexo to the Food & Drug Retailing industry mean.
  • -1.4% Return on Equity means Curexo generated ₩-0.01 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Curexo Inc:

  • The MRQ is -1.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -2.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.4%TTM-2.5%+1.1%
TTM-2.5%YOY0.5%-3.0%
TTM-2.5%5Y-2.2%-0.3%
5Y-2.2%10Y-3.6%+1.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Curexo Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Curexo is operating .

  • Measures how much profit Curexo makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Curexo to the Food & Drug Retailing industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Curexo Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-21.1%+21.1%
4.3.2.2. Operating Ratio

Measures how efficient Curexo is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Food & Drug Retailing industry mean).
  • An Operation Ratio of 1.52 means that the operating costs are ₩1.52 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Curexo Inc:

  • The MRQ is 1.516. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.720. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.516TTM1.720-0.204
TTM1.720YOY1.418+0.302
TTM1.7205Y1.104+0.616
5Y1.10410Y1.378-0.274
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Curexo Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Curexo is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Food & Drug Retailing industry mean).
  • A Current Ratio of 10.70 means the company has ₩10.70 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Curexo Inc:

  • The MRQ is 10.703. The company is very able to pay all its short-term debts. +2
  • The TTM is 15.413. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ10.703TTM15.413-4.710
TTM15.413YOY7.401+8.012
TTM15.4135Y10.740+4.673
5Y10.74010Y7.913+2.827
4.4.3.2. Quick Ratio

Measures if Curexo is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Curexo to the Food & Drug Retailing industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Curexo Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM6.571-6.571
TTM6.571YOY6.601-0.031
TTM6.5715Y5.642+0.929
5Y5.64210Y4.126+1.516
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Curexo Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Curexo assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Curexo to Food & Drug Retailing industry mean.
  • A Debt to Asset Ratio of 0.09 means that Curexo assets are financed with 9.5% credit (debt) and the remaining percentage (100% - 9.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Curexo Inc:

  • The MRQ is 0.095. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.074. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.095TTM0.074+0.020
TTM0.074YOY0.135-0.061
TTM0.0745Y0.138-0.064
5Y0.13810Y0.186-0.048
4.5.4.2. Debt to Equity Ratio

Measures if Curexo is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Curexo to the Food & Drug Retailing industry mean.
  • A Debt to Equity ratio of 10.5% means that company has ₩0.10 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Curexo Inc:

  • The MRQ is 0.105. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.081. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.105TTM0.081+0.024
TTM0.081YOY0.160-0.079
TTM0.0815Y0.174-0.093
5Y0.17410Y0.303-0.129
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Curexo generates.

  • Above 15 is considered overpriced but always compare Curexo to the Food & Drug Retailing industry mean.
  • A PE ratio of -69.87 means the investor is paying ₩-69.87 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Curexo Inc:

  • The EOD is -54.184. Based on the earnings, the company is expensive. -2
  • The MRQ is -69.869. Based on the earnings, the company is expensive. -2
  • The TTM is -34.208. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-54.184MRQ-69.869+15.685
MRQ-69.869TTM-34.208-35.661
TTM-34.208YOY58.371-92.579
TTM-34.2085Y-11.034-23.174
5Y-11.03410Y-9.358-1.676
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Curexo Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM64.947-64.947
TTM64.947YOY102.251-37.304
TTM64.9475Y27.530+37.417
5Y27.53010Y18.323+9.207
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Curexo is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Food & Drug Retailing industry mean).
  • A PB ratio of 4.02 means the investor is paying ₩4.02 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Curexo Inc:

  • The EOD is 3.116. Based on the equity, the company is fair priced.
  • The MRQ is 4.018. Based on the equity, the company is fair priced.
  • The TTM is 6.032. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD3.116MRQ4.018-0.902
MRQ4.018TTM6.032-2.014
TTM6.032YOY4.719+1.313
TTM6.0325Y5.192+0.840
5Y5.19210Y5.418-0.226
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-06-302023-09-302023-12-312024-03-312024-06-30
Net Interest Income  414,947-152,573262,374234,620496,994-282,217214,778-369,825-155,047



6.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets110,683,602
Total Liabilities10,472,388
Total Stockholder Equity100,211,214
 As reported
Total Liabilities 10,472,388
Total Stockholder Equity+ 100,211,214
Total Assets = 110,683,602

Assets

Total Assets110,683,602
Total Current Assets94,308,937
Long-term Assets16,374,665
Total Current Assets
Total Current Assets  (as reported)94,308,937
Total Current Assets  (calculated)0
+/- 94,308,937
Long-term Assets
Long-term Assets  (as reported)16,374,665
Long-term Assets  (calculated)0
+/- 16,374,665

Liabilities & Shareholders' Equity

Total Current Liabilities8,811,594
Long-term Liabilities1,660,794
Total Stockholder Equity100,211,214
Total Current Liabilities
Total Current Liabilities  (as reported)8,811,594
Total Current Liabilities  (calculated)0
+/- 8,811,594
Long-term Liabilities
Long-term Liabilities  (as reported)1,660,794
Long-term Liabilities  (calculated)0
+/- 1,660,794
Total Stockholder Equity
Total Stockholder Equity (as reported)100,211,214
Total Stockholder Equity (calculated)0
+/- 100,211,214
Other
Common Stock Shares Outstanding 41,085
Net Working Capital 85,497,343



6.3. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
50,244,012
48,427,755
43,135,930
39,537,735
45,375,154
40,887,723
42,928,872
40,335,195
74,137,527
68,453,154
69,877,804
58,625,344
48,350,690
49,695,071
49,682,897
51,272,743
47,125,377
46,772,877
47,732,703
47,386,859
48,878,698
46,803,014
62,682,545
61,291,970
61,305,978
60,371,404
100,940,158
102,310,303
98,397,868
103,031,165
108,192,058
108,478,357
107,369,633
108,543,602
110,683,602
110,683,602108,543,602107,369,633108,478,357108,192,058103,031,16598,397,868102,310,303100,940,15860,371,40461,305,97861,291,97062,682,54546,803,01448,878,69847,386,85947,732,70346,772,87747,125,37751,272,74349,682,89749,695,07148,350,69058,625,34469,877,80468,453,15474,137,52740,335,19542,928,87240,887,72345,375,15439,537,73543,135,93048,427,75550,244,012
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
41,248,781
32,110,325
32,494,020
31,497,429
36,596,660
35,923,548
35,526,251
36,679,754
36,245,249
39,064,295
36,678,380
49,957,978
48,043,307
50,470,877
49,431,232
89,726,103
78,293,526
75,951,520
80,899,822
91,484,793
93,073,435
90,831,324
92,222,728
94,308,937
94,308,93792,222,72890,831,32493,073,43591,484,79380,899,82275,951,52078,293,52689,726,10349,431,23250,470,87748,043,30749,957,97836,678,38039,064,29536,245,24936,679,75435,526,25135,923,54836,596,66031,497,42932,494,02032,110,32541,248,78100000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
18,247,645
7,305,121
7,173,769
8,059,164
1,547,495
1,971,316
1,157,948
2,561,284
892,227
2,506,741
552,846
458
671
419
854
981
613
664
864
943
4,016,006
17,091,911
4,726,632
0
04,726,63217,091,9114,016,006943864664613981854419671458552,8462,506,741892,2272,561,2841,157,9481,971,3161,547,4958,059,1647,173,7697,305,12118,247,64500000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,000,000
3,500,000
3,500,000
11,000,000
5,000,000
5,000,000
509,003
509,453
23,942,181
19,525,581
20,529,417
31,554,342
30,271,073
17,691,020
30,061,430
0
030,061,43017,691,02030,271,07331,554,34220,529,41719,525,58123,942,181509,453509,0035,000,0005,000,00011,000,0003,500,0003,500,0003,000,0000000000000000000000
       Net Receivables 
10,385,469
12,220,899
7,101,048
9,647,267
7,866,837
8,383,320
6,018,385
6,523,450
7,969,884
7,093,540
6,031,181
6,568,425
6,387,507
7,404,694
7,072,246
8,193,669
8,976,623
9,146,786
7,161,306
7,786,340
11,064,068
9,324,476
10,367,459
10,200,930
12,583,921
14,315,105
12,480,286
13,556,749
17,316,123
25,675,171
25,573,784
23,640,564
21,767,275
20,490,260
0
020,490,26021,767,27523,640,56425,573,78425,675,17117,316,12313,556,74912,480,28614,315,10512,583,92110,200,93010,367,4599,324,47611,064,0687,786,3407,161,3069,146,7868,976,6238,193,6697,072,2467,404,6946,387,5076,568,4256,031,1817,093,5407,969,8846,523,4506,018,3858,383,3207,866,8379,647,2677,101,04812,220,89910,385,469
       Other Current Assets 
342,953
3,092,245
3,402,838
2,899,304
3,039,321
3,207,367
2,688,480
2,716,935
2,689,733
2,751,316
2,955,793
2,260,417
2,522,346
421,563
490,184
0
0
0
0
0
0
0
0
0
1,101,574
1,101,574
891,713
5,555,420
442,262
163,637
1
0
0
0
0
00001163,637442,2625,555,420891,7131,101,5741,101,574000000000490,184421,5632,522,3462,260,4172,955,7932,751,3162,689,7332,716,9352,688,4803,207,3673,039,3212,899,3043,402,8383,092,245342,953
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22,446,348
22,131,343
16,707,265
15,404,922
16,538,310
16,320,874
16,374,665
16,374,66516,320,87416,538,31015,404,92216,707,26522,131,34322,446,3480000000000000000000000000000
       Property Plant Equipment 
1,941,629
2,035,759
1,987,316
1,977,531
2,075,923
1,924,463
1,842,550
2,872,832
2,796,174
1,569,781
3,303,488
3,463,737
3,117,914
2,652,960
2,685,605
2,535,737
1,774,164
1,844,735
1,929,105
1,195,672
1,372,184
1,257,175
1,105,761
1,487,505
1,863,980
2,059,592
2,242,093
2,265,883
2,741,111
2,199,139
4,688,396
5,500,781
6,638,067
6,662,220
0
06,662,2206,638,0675,500,7814,688,3962,199,1392,741,1112,265,8832,242,0932,059,5921,863,9801,487,5051,105,7611,257,1751,372,1841,195,6721,929,1051,844,7351,774,1642,535,7372,685,6052,652,9603,117,9143,463,7373,303,4881,569,7812,796,1742,872,8321,842,5501,924,4632,075,9231,977,5311,987,3162,035,7591,941,629
       Goodwill 
5,122,450
5,122,450
5,122,450
5,122,450
5,122,450
5,122,450
5,122,450
4,925,694
4,925,694
4,925,694
4,925,694
4,925,694
4,925,694
4,925,694
4,925,694
7,010,459
4,352,849
4,352,849
4,352,849
4,352,849
4,352,849
4,352,849
4,352,849
4,352,849
1,357,737
1,357,737
1,357,737
1,357,737
0
0
0
0
0
0
0
00000001,357,7371,357,7371,357,7371,357,7374,352,8494,352,8494,352,8494,352,8494,352,8494,352,8494,352,8494,352,8497,010,4594,925,6944,925,6944,925,6944,925,6944,925,6944,925,6944,925,6944,925,6945,122,4505,122,4505,122,4505,122,4505,122,4505,122,4505,122,450
       Intangible Assets 
5,594,656
5,575,470
5,536,470
5,425,950
5,405,925
5,380,806
5,362,050
5,141,370
5,120,664
5,100,795
5,084,259
139,754
135,141
118,787
97,217
423,717
405,937
373,860
357,975
1,162,346
1,152,254
1,144,594
1,071,617
1,006,344
1,148,206
1,116,181
1,087,656
1,048,253
990,645
986,344
914,079
833,945
792,826
719,433
0
0719,433792,826833,945914,079986,344990,6451,048,2531,087,6561,116,1811,148,2061,006,3441,071,6171,144,5941,152,2541,162,346357,975373,860405,937423,71797,217118,787135,141139,7545,084,2595,100,7955,120,6645,141,3705,362,0505,380,8065,405,9255,425,9505,536,4705,575,4705,594,656
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
0
0
0
0
0000-1000000000000000000000000000000
> Total Liabilities 
2,714,172
4,517,193
4,046,829
4,452,066
14,631,821
14,504,699
22,254,641
26,394,288
6,002,493
6,301,385
6,329,655
6,438,416
6,436,531
18,277,111
29,447,736
2,946,355
3,145,443
3,509,264
5,357,724
4,386,927
4,084,019
3,315,299
18,300,366
17,993,827
18,404,311
17,864,857
19,079,740
19,425,924
16,717,331
10,476,885
8,587,433
8,021,074
6,941,053
6,966,860
10,472,388
10,472,3886,966,8606,941,0538,021,0748,587,43310,476,88516,717,33119,425,92419,079,74017,864,85718,404,31117,993,82718,300,3663,315,2994,084,0194,386,9275,357,7243,509,2643,145,4432,946,35529,447,73618,277,1116,436,5316,438,4166,329,6556,301,3856,002,49326,394,28822,254,64114,504,69914,631,8214,452,0664,046,8294,517,1932,714,172
   > Total Current Liabilities 
2,447,742
4,238,430
3,864,238
4,190,748
14,339,444
14,308,167
22,032,557
25,988,802
5,698,037
6,082,974
6,080,372
6,240,773
6,205,731
18,013,154
29,150,622
2,742,752
2,521,688
2,797,376
4,639,701
3,613,184
3,409,253
2,686,318
3,687,526
2,943,697
18,270,580
17,722,625
18,772,965
19,156,884
16,588,731
10,405,454
6,949,210
6,443,637
4,932,863
5,097,663
8,811,594
8,811,5945,097,6634,932,8636,443,6376,949,21010,405,45416,588,73119,156,88418,772,96517,722,62518,270,5802,943,6973,687,5262,686,3183,409,2533,613,1844,639,7012,797,3762,521,6882,742,75229,150,62218,013,1546,205,7316,240,7736,080,3726,082,9745,698,03725,988,80222,032,55714,308,16714,339,4444,190,7483,864,2384,238,4302,447,742
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
3,000,000
3,000,000
14,647,000
24,926,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000024,926,00014,647,0003,000,0003,000,00000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
3,000,000
3,000,000
14,647,000
24,926,000
0
0
0
0
0
0
0
0
0
0
0
0
6,589,348
6,742,286
2,494,646
0
0
0
0
0
000002,494,6466,742,2866,589,34800000000000024,926,00014,647,0003,000,0003,000,00000000000000
       Accounts payable 
1,409,800
1,254,250
1,018,358
1,165,866
1,778,321
2,003,778
1,300,451
2,343,714
1,646,455
1,731,230
2,051,122
1,737,051
1,565,503
1,693,871
2,187,515
0
0
0
0
0
0
0
0
0
0
0
0
0
731,978
3,337,619
5,293,199
4,468,339
3,159,461
3,583,693
0
03,583,6933,159,4614,468,3395,293,1993,337,619731,97800000000000002,187,5151,693,8711,565,5031,737,0512,051,1221,731,2301,646,4552,343,7141,300,4512,003,7781,778,3211,165,8661,018,3581,254,2501,409,800
       Other Current Liabilities 
1,037,942
984,180
845,880
1,024,882
873,123
1,160,389
1,296,006
1,661,088
1,051,582
1,351,744
1,029,250
159,960
453,985
579,514
764,552
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
1
2
1
0
0121-1000000000000000764,552579,514453,985159,9601,029,2501,351,7441,051,5821,661,0881,296,0061,160,389873,1231,024,882845,880984,1801,037,942
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
128,599
71,431
1,638,224
1,577,437
2,008,190
1,869,197
1,660,794
1,660,7941,869,1972,008,1901,577,4371,638,22471,431128,5990000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
58,739
53,651
199,281
203,306
152,666
101,526
4,758,915
5,098,173
82,336
66,614
216,799
157,144
128,599
71,431
1,638,224
0
0
0
0
00001,638,22471,431128,599157,144216,79966,61482,3365,098,1734,758,915101,526152,666203,306199,28153,65158,7390000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
-3,000,000
-3,000,000
-14,647,000
-24,926,000
0
0
0
0
0
0
0
0
0
0
0
0
0
371,017
309,491
2,410,809
2,154,774
2,059,364
1,916,397
0
01,916,3972,059,3642,154,7742,410,809309,491371,0170000000000000-24,926,000-14,647,000-3,000,000-3,000,00000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
6,972,125
6,518,966
6,235,828
5,543,523
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000005,543,5236,235,8286,518,9666,972,12500000000000
> Total Stockholder Equity
37,042,988
34,963,067
32,525,114
30,445,625
28,355,824
26,258,870
23,530,646
19,105,544
39,592,742
37,423,874
37,975,025
33,507,892
29,685,780
25,749,517
21,618,158
48,326,388
43,979,934
43,263,613
42,374,979
42,999,932
44,794,679
43,487,715
44,382,179
43,298,143
42,901,667
42,506,548
81,860,418
82,884,380
81,680,537
92,554,280
99,604,625
100,457,283
100,428,580
101,576,742
100,211,214
100,211,214101,576,742100,428,580100,457,28399,604,62592,554,28081,680,53782,884,38081,860,41842,506,54842,901,66743,298,14344,382,17943,487,71544,794,67942,999,93242,374,97943,263,61343,979,93448,326,38821,618,15825,749,51729,685,78033,507,89237,975,02537,423,87439,592,74219,105,54423,530,64626,258,87028,355,82430,445,62532,525,11434,963,06737,042,988
   Common Stock
13,477,433
13,477,433
13,477,433
13,477,433
13,477,433
13,477,433
13,477,433
13,477,433
13,477,433
13,477,433
13,477,433
13,477,433
13,477,433
13,477,433
13,477,433
16,678,627
16,678,627
16,678,627
16,678,627
16,678,627
16,701,531
16,718,709
16,718,709
16,718,709
16,724,435
16,724,435
16,724,435
19,453,545
19,453,545
20,098,949
20,477,995
0
0
0
0
000020,477,99520,098,94919,453,54519,453,54516,724,43516,724,43516,724,43516,718,70916,718,70916,718,70916,701,53116,678,62716,678,62716,678,62716,678,62716,678,62713,477,43313,477,43313,477,43313,477,43313,477,43313,477,43313,477,43313,477,43313,477,43313,477,43313,477,43313,477,43313,477,43313,477,43313,477,433
   Retained Earnings 
508,418
0
508,418
508,418
508,418
508,418
508,418
508,418
508,418
508,418
2,101,907
-81,786,703
-85,638,397
-89,702,797
-93,781,137
-123,792,807
-130,498,460
-131,255,279
-132,143,912
-131,518,959
-130,047,957
-131,607,088
-130,712,625
-131,796,660
-132,315,671
-132,725,756
-134,066,436
-133,213,757
-134,994,102
-133,129,258
-131,627,753
-131,092,371
-140,130,761
-140,501,412
0
0-140,501,412-140,130,761-131,092,371-131,627,753-133,129,258-134,994,102-133,213,757-134,066,436-132,725,756-132,315,671-131,796,660-130,712,625-131,607,088-130,047,957-131,518,959-132,143,912-131,255,279-130,498,460-123,792,807-93,781,137-89,702,797-85,638,397-81,786,7032,101,907508,418508,418508,418508,418508,418508,418508,418508,4180508,418
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
154,462,284
154,490,700
154,531,197
154,531,197
154,531,197
154,492,236
154,727,225
154,727,225
154,727,225
154,844,034
154,844,034
154,844,034
192,589,517
192,589,517
200,753,960
209,330,862
0
0
0
0
0000209,330,862200,753,960192,589,517192,589,517154,844,034154,844,034154,844,034154,727,225154,727,225154,727,225154,492,236154,531,197154,531,197154,531,197154,490,700154,462,284000000000000000
   Treasury Stock00000000000000000000-881,078-881,078-881,078-881,078-881,078-881,078-881,078-881,078-881,078-881,078-881,078-881,078-881,078-881,078-881,078
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
268,799
245,602
-190,783
-293,964
3,698,903
3,698,903
3,698,903
3,698,903
3,698,903
3,698,903
3,698,903
3,698,903
3,698,903
3,698,903
3,698,903
44,198,903
3,698,903
3,698,903
3,698,903
0
0
0
0
0
000003,698,9033,698,9033,698,90344,198,9033,698,9033,698,9033,698,9033,698,9033,698,9033,698,9033,698,9033,698,9033,698,9033,698,9033,698,903-293,964-190,783245,602268,79900000000000



6.4. Balance Sheets

Currency in KRW. All numbers in thousands.




6.5. Cash Flows

Currency in KRW. All numbers in thousands.




6.6. Income Statements

Currency in KRW. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue72,882,216
Cost of Revenue-53,583,836
Gross Profit19,298,38019,298,380
 
Operating Income (+$)
Gross Profit19,298,380
Operating Expense-71,746,774
Operating Income1,135,442-52,448,395
 
Operating Expense (+$)
Research Development7,604,941
Selling General Administrative4,754,355
Selling And Marketing Expenses0
Operating Expense71,746,77412,359,296
 
Net Interest Income (+$)
Interest Income1,326,602
Interest Expense-414,229
Other Finance Cost-0
Net Interest Income912,373
 
Pretax Income (+$)
Operating Income1,135,442
Net Interest Income912,373
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-4,759,9181,135,442
EBIT - interestExpense = -414,229
-4,856,019
-4,441,791
Interest Expense414,229
Earnings Before Interest and Taxes (EBIT)0-4,345,689
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-4,759,918
Tax Provision-96,102
Net Income From Continuing Ops-4,856,019-4,856,019
Net Income-4,856,019
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-912,373
 

Technical Analysis of Curexo
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Curexo. The general trend of Curexo is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Curexo's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Curexo Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 7,900 < 7,900 < 8,200.

The bearish price targets are: 7,080 > 5,980.

Tweet this
Curexo Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Curexo Inc. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Curexo Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Curexo Inc. The current macd is 77.26.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Curexo price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Curexo. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Curexo price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Curexo Inc Daily Moving Average Convergence/Divergence (MACD) ChartCurexo Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Curexo Inc. The current adx is 30.17.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Curexo shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Curexo Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Curexo Inc. The current sar is 6,326.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Curexo Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Curexo Inc. The current rsi is 63.67. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Curexo Inc Daily Relative Strength Index (RSI) ChartCurexo Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Curexo Inc. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Curexo price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Curexo Inc Daily Stochastic Oscillator ChartCurexo Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Curexo Inc. The current cci is 167.49.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Curexo Inc Daily Commodity Channel Index (CCI) ChartCurexo Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Curexo Inc. The current cmo is 41.18.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Curexo Inc Daily Chande Momentum Oscillator (CMO) ChartCurexo Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Curexo Inc. The current willr is -14.28571429.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Curexo Inc Daily Williams %R ChartCurexo Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Curexo Inc.

Curexo Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Curexo Inc. The current atr is 356.87.

Curexo Inc Daily Average True Range (ATR) ChartCurexo Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Curexo Inc. The current obv is 99,431,870.

Curexo Inc Daily On-Balance Volume (OBV) ChartCurexo Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Curexo Inc. The current mfi is 66.08.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Curexo Inc Daily Money Flow Index (MFI) ChartCurexo Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Curexo Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-04STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-11MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-17STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-07-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-30RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-26STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Curexo Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Curexo Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.671
Ma 20Greater thanMa 506,772.500
Ma 50Greater thanMa 1007,063.600
Ma 100Greater thanMa 2008,142.800
OpenGreater thanClose7,550.000
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Curexo with someone you think should read this too:
  • Are you bullish or bearish on Curexo? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Curexo? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Curexo Inc

I send you an email if I find something interesting about Curexo Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Curexo Inc.

Receive notifications about Curexo Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.